Nearly one-third of pediatric patients receiving intensive chemotherapy and undergoing hematopoietic stem cell transplantation (HSCT) are receiving inappropriate prescriptions for levofloxacin, raising the risk for antibiotic resistance, according to a new study presented at ASHP Pharmacy Futures 2024 (36-M).